JP2024540097A5 - - Google Patents
Info
- Publication number
- JP2024540097A5 JP2024540097A5 JP2024525379A JP2024525379A JP2024540097A5 JP 2024540097 A5 JP2024540097 A5 JP 2024540097A5 JP 2024525379 A JP2024525379 A JP 2024525379A JP 2024525379 A JP2024525379 A JP 2024525379A JP 2024540097 A5 JP2024540097 A5 JP 2024540097A5
- Authority
- JP
- Japan
- Prior art keywords
- molecule
- nucleic acid
- group
- target nucleic
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2115540.3 | 2021-10-28 | ||
| GBGB2115540.3A GB202115540D0 (en) | 2021-10-28 | 2021-10-28 | Methods for nucleic acid cleavage |
| PCT/EP2022/080220 WO2023073181A2 (en) | 2021-10-28 | 2022-10-28 | Methods for nucleic acid cleavage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540097A JP2024540097A (ja) | 2024-10-31 |
| JP2024540097A5 true JP2024540097A5 (cg-RX-API-DMAC7.html) | 2025-11-05 |
Family
ID=78828356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525379A Pending JP2024540097A (ja) | 2021-10-28 | 2022-10-28 | 核酸切断のための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240417778A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4423295A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024540097A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022378590A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3236292A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202115540D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023073181A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202300886D0 (en) * | 2023-01-20 | 2023-03-08 | Cambridge Entpr Ltd | Compounds for nucleic acid cleavage |
| GB202300884D0 (en) * | 2023-01-20 | 2023-03-08 | Cambridge Entpr Ltd | Compounds for nucleic acid cleavage |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230272460A1 (en) * | 2020-08-12 | 2023-08-31 | Cambridge Enterprise Limited | Method for Targeted Nucleic Acid Cleavage |
-
2021
- 2021-10-28 GB GBGB2115540.3A patent/GB202115540D0/en not_active Ceased
-
2022
- 2022-10-28 AU AU2022378590A patent/AU2022378590A1/en active Pending
- 2022-10-28 US US18/702,310 patent/US20240417778A1/en active Pending
- 2022-10-28 WO PCT/EP2022/080220 patent/WO2023073181A2/en not_active Ceased
- 2022-10-28 EP EP22813156.1A patent/EP4423295A2/en active Pending
- 2022-10-28 CA CA3236292A patent/CA3236292A1/en active Pending
- 2022-10-28 JP JP2024525379A patent/JP2024540097A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7454760B2 (ja) | ナノポア配列決定で使用するための移動制御エレメント、レポーターコード、および移動制御のためのさらなる手段 | |
| JP2021531826A5 (cg-RX-API-DMAC7.html) | ||
| US12029790B2 (en) | Biomimetic nanomaterials and uses thereof | |
| JP5346585B2 (ja) | カチオン性オリゴヌクレオチド、同ヌクレオチドの自動調製法およびそれらの使用 | |
| US9962449B2 (en) | MultiLigand agent for drug delivery | |
| JP2024028453A5 (cg-RX-API-DMAC7.html) | ||
| CN106279300B (zh) | Rig-i配体及其生产方法 | |
| JP2022507282A5 (cg-RX-API-DMAC7.html) | ||
| JP2021011503A5 (ja) | 製剤用脂質ナノ粒子 | |
| RU2016142510A (ru) | Соединения и способы для транс-мембранной доставки молекул | |
| JPH09504515A (ja) | ポリマー変性 | |
| JP2013525414A5 (cg-RX-API-DMAC7.html) | ||
| JP2013540841A5 (cg-RX-API-DMAC7.html) | ||
| KR960701888A (ko) | 신규의 펩티드 핵산 | |
| RU2011150787A (ru) | КОНЪЮГАТ миРНК И СПОСОБ ЕГО ПОЛУЧЕНИЯ | |
| JP2011522070A (ja) | ミセル集合体 | |
| AR052441A1 (es) | Suspension no acuosa inyectable | |
| JP2022512941A5 (cg-RX-API-DMAC7.html) | ||
| TW490306B (en) | Compositions and methods for enhancing delivery of therapeutic agents to cells | |
| JP2013510181A5 (cg-RX-API-DMAC7.html) | ||
| WO2007099660A1 (ja) | 核酸内包高分子ミセル複合体 | |
| JP2025542331A (ja) | 新規rna治療薬及びその使用 | |
| CA3232690A1 (en) | Multi-motif dendrons and their supramolecular structures and uses thereof | |
| CN118108613A (zh) | 一种阳离子脂质化合物及制备方法和应用、mRNA递送系统 | |
| McCollum et al. | Safety and biodistribution of nanoligomers targeting the SARS-CoV-2 genome for the treatment of COVID-19 |